Coagulation factor IX complex Other names: Prothrombin complex concentrate

Active ingredient description

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code Group title Classification
B02BD01 Coagulation factor IX, II, VII and X in combination B Blood and blood forming organs → B02 Antihemorrhagics → B02B Vitamin K and other hemostatics → B02BD Blood coagulation factors
Discover more medicines within B02BD01

External identifiers

CAS Substance: 37224-63-8
DrugBank Drug: DB11330
KEGG Drug: D08794
RxNorm Ingredient: 1670383
SNOMED-CT Concept: 54144004
Factor IX complex (substance)
UNII Identifier: FW411QXD5M
FACTOR IX COMPLEX

Medicines

Coagulation factor IX complex is an active ingredient of these brands:

United States (US)

  • (combination) KCENTRA as Prothrombin complex concentrate

Japan (JP)

  • (combination) KCENTRA as Prothrombin complex concentrate

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.

 
Next: Usage >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈